Development and Validation of an Endometriosis Diagnostic Method Based on Serum Biomarkers and Clinical Variables
Endometriosis affects more than 10% of women of reproductive age, significantly impacting their quality of life. Diagnosis typically takes 4 to 11 years from symptom onset. The gold standard for diagnosing this disease, laparoscopy, is invasive, contributing to this delay in diagnosis. Two studies w...
Main Authors: | Bárbara Herranz-Blanco, Elza Daoud, Paola Viganò, Juan Antonio García-Velasco, Enrico Colli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/7/1052 |
Similar Items
-
Determination of Serum Arginase-1 Concentrations and Serum Arginase Activity for the Non-Invasive Diagnosis of Endometriosis
by: Maciej Pliszkiewicz, et al.
Published: (2024-03-01) -
Metabolomics as a Candidate for Endometriosis Biomarker: A Systematic Review
by: Shafira Meidyana, et al.
Published: (2024-03-01) -
Biomarkers of endometriosis: How far have we come and where are we going?
by: Vid Janša, et al.
Published: (2021-06-01) -
Diagnostic gene biomarkers for predicting immune infiltration in endometriosis
by: Chengmao Xie, et al.
Published: (2022-05-01) -
A Systematic Review of Atypical Endometriosis-Associated Biomarkers
by: Ludovica Bartiromo, et al.
Published: (2022-04-01)